Skip to content
Dx

ICD-10-PCS 2027 procedure code

3E0Y4GCIntroduction of Other Therapeutic Substance into Pericardial Cavity, Percutaneous Endoscopic Approach

✓ Valid for 2027

Short description: Introduce Oth Therap Subst in Pericard Cav, Perc Endo

Code last changed in FY2018 (effective October 1, 2017). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About 3E0Y4GC

3E0Y4GC is the ICD-10-PCS code for a introduction procedure on the pericardial cavity using a percutaneous endoscopic approach with other therapeutic substance (qualifier: other substance). In ICD-10-PCS, introduction means putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

In plain terms, this corresponds to injection into thoracic cavity, the ICD-9-CM procedure title it maps to (34.92).

For a different body part, codes include 3E074GC (coronary artery), 3E084GC (heart), 3E0E4GC (products of conception), 3E0F4GC (respiratory tract), 3E0G4GC (upper GI), 3E0H4GC (lower GI) and 8 more.

The same procedure with a different approach is coded 3E0Y3GC (percutaneous).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2018, effective October 1, 2017.

What each character means

1. Section
3Administration
2. Body System
EPhysiological Systems and Anatomical Regions
3. Operation
0Introduction

Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

4. Body System / Region
YPericardial Cavity
5. Approach
4Percutaneous Endoscopic

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach and visualize the site of the procedure

6. Substance
GOther Therapeutic Substance

Includes: Anacaulase-bcdb; Bromelain-enriched Proteolytic Enzyme; Collagenase SANTYL Ointment; COSELA(tm) (Trilaciclib); ENSPRYNG(tm) (Satralizumab-mwge); Fostamatinib; Idarucizumab, Pradaxa(R)(dabigatran) reversal agent; NexoBrid(tm); Praxbind(R) (idarucizumab), Pradaxa(R)(dabigatran) reversal agent; SANTYL Ointment; Satralizumab-mwge; TAVALISSE(R); Trilaciclib

7. Qualifier
COther Substance

Other versions of this procedure

Different approach

ICD-9-CM equivalent

Converter →
  • 34.92Injection into thoracic cavityapproximate

From the CMS 2018 General Equivalence Mappings (GEMs), the final GEMs release.

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2018 (effective 10/1/2017): Added
  • No changes since FY2018.

Common questions about 3E0Y4GC

Is 3E0Y4GC a valid ICD-10-PCS code for 2027?

Yes. 3E0Y4GC is valid for inpatient procedures from October 1, 2026 through September 30, 2027.

What is the ICD-9 procedure code for 3E0Y4GC?

The CMS GEMs map 3E0Y4GC to ICD-9-CM 34.92 (Injection into thoracic cavity).